Causes and contemporary epidemiology of pediatric uveitis – a current review of the literature

Monika Modrzejewska, Oliwia Zdanowska, Dawid Świstara

Abstract


Uveitis is a group of diseases that are prevalent worldwide and can lead to serious ophthalmic complications that threaten vision. In the pediatric population, uveitis often presents as a systemic disease with a severe course. Early diagnosis of the causative disease entity for uveitis is often delayed due to the limited cooperation of pediatric patients. Although most cases of uveitis are idiopathic (40%), understanding the potential complications and multiorgan involvement facilitates multidisciplinary pediatric care and allows for earlier initiation of appropriate treatment, prevention and reduction of ocular complications, thus contributing to the normal development of the child. In the first part of this article, the authors reviewed the current literature (2018–2023) from PubMed and Google Scholar to present an updated perspective on the classification and causes of uveitis. Due to the lack of recent data on the prevalence of specific types of uveitis in the pediatric population in Poland, the authors referred to statistical analyses from 2001–2006.

Keywords


uveitis in children; etiology of uveitis; incidence of uveitis in children

Full Text:

PDF

References


Chan NS, Choi J, Cheung CMG. Pediatric Uveitis. Asia Pac J Ophthalmol (Phila). 2018;7(3):192-9. doi: 10.22608/APO.2018116.

Al-Haddad C, BouGhannam A, Abdul Fattah M, Tamim H, El Moussawi Z, Hamam RN. Patterns of uveitis in children according to age: comparison of visual outcomes and complications in a tertiary center. BMC Ophthalmol 2019;19(1):137.

Shin Y, Kang JM, Lee J, Lee CS, Lee SC, Ahn JG. Epidemiology of pediatric uveitis and associated systemic diseases. Pediatr Rheumatol Online J 2021;19(1):48. doi: 10.1186/s12969-021-00516-2.

Heiligenhaus A, Rothaus K, Pleyer U. Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group. Ophthalmologe 2021;118(9):913-8.

Iwanejko M, Turno-Kręcicka A, Barć A. Analysis of rate, types and causes of uveitis in children hospitalized at Ophthalmology Clinic in Wroclaw in years 2001–2006. Klin Oczna 2010;112(1):29-32.

Pleyer U, Heiligenhaus A. Here comes the „SUN“... Ophthalmologe 2021;118(9):881-2.

Maleki A, Anesi SD, Look-Why S, Manhapra A, Foster CS. Pediatric uveitis: a comprehensive review. Surv Ophthalmol 2022;67(2):510-29.

Khan K, Khan W. Congenital toxoplasmosis: an overview of the neurological and ocular manifestations. Parasitol Int 2018;67(6):715-21.

Murthy SR, Ganesh S, C K M, Dubey N. Pediatric uveitis: a retrospective analysis at a tertiary eye care hospital in South India. Ther Adv Ophthalmol 2021;13:25158414211027707. doi: 10.1177/25158414211027707.

Paroli MP, Restivo L, Ottaviani E, Nardella C, Abicca I, Spadea L, et al. Clinical features of infectious uveitis in children referred to a hospital-based eye clinic in Italy. Medicina (Kaunas) 2022;58(11):1673.

Curragh DS, O’Neill M, McAvoy CE, Rooney M, McLoone E. Pediatric Uveitis in a well-defined population: improved outcomes with immunosuppressive therapy. Ocul Immunol Inflamm 2018;26(6):978-85.

Rodier-Bonifas C, Rochet E, Seve P, Duquesne A, Nguyen AM, Denis P, et al. Uveitis in children: epidemiological, clinical and prognostic characteristics. J Fr Ophtalmol 2023;46(2):163-72.

Smith LM, Ismail OM, Mojica G. Ocular manifestations of herpes simplex virus in the pediatric population. Int Ophthalmol Clin 2022;62(1):73-81.

Habot-Wilner Z, Trivizki O, Goldstein M, Kesler A, Shulman S, Horowitz J, et al. Cat-scratch disease: ocular manifestations and treatment outcome. Acta Ophthalmol 2018;96(4):e524-32.

Mazurek Ł, Winiarczyk S, Adaszek Ł. Choroba kociego pazura jako zoonoza: patogeneza, objawy kliniczne, rozpoznawanie. Med Weter 2018;74(11):693-696. doi: 10.21521/mw.5997.

Baranowski K, Huang B. Cat Scratch Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.

Armitano R, Lisa A, Martínez C, Cipolla L, Iachini R, Prieto M. Bartonella henselae: Serological evidence in pediatric patients with clinical suspicion of cat scratch disease. Rev Argent Microbiol 2018;50(4):365-8.

Agrawal R, Betzler B, Testi I, Mahajan S, Agarwal A, Gunasekeran DV, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 165 patients with tubercular anterior uveitis. Ocul Immunol Inflamm 2020;28(sup1):17-26. doi: 10.1080/09273948.2020.1761400.

Mohan M, Garg SP, Kumar H, Raj M. SAFA test as an aid to the diagnosis of ocular tuberculosis. Indian J Ophthalmol 1990;38(2):57-60.

Kępa B, Grałek M, Kanigowska K, Chipczyńska B. Ocular changes in course of Mycobacterium tuberculosis infection – own observations. Klin Oczna 2008;110(7-9):265-8.

Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, et al. Collaborative Ocular Tuberculosis Study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis. Ophthalmology 2021;128(2):266-76.

Burek A, Turno-Kręcicka A. Diagnostic challenges in presumably endogeneous fungal endophthalmitis. Klin Oczna 2016;118(3):250-4.

Son HJ, Kim MJ, Lee S, Choi S, Jung KH, Jung J, et al. Risk factors and outcomes of patients with ocular involvement of candidemia. PLoS One 2019;14(9):e0222356.

Majumder PD, Biswas J. Pediatric uveitis: An update. Oman J Ophthalmol 2013;6(3):140-50.

Rothova A, Hajjaj A, de Hoog J, Thiadens AAHJ, Dalm VASH. Uveitis causes according to immune status of patients. Acta Ophthalmol 2019;97(1):53-9.

Cunningham ET Jr, Moorthy RS, Fraunfelder FW, Zierhut M. Vaccine-associated uveitis. Ocul Immunol Inflamm 2019;27(4):517-20. doi: 10.1080/09273948.2019.1626188.

Singh RB, Parmar UPS, Kahale F, Agarwal A, Tsui E. Vaccine-associated uveitis after COVID-19 vaccination: vaccine adverse event reporting system database analysis. Ophthalmology 2023;130(2):179-86.

Yasaka Y, Hasegawa E, Keino H, Usui Y, Maruyama K, Yamamoto Y, et al. A multicenter study of ocular inflammation after COVID-19 vaccination. Jpn J Ophthalmol 2023;67(1):14-21.

Ferrand N, Accorinti M, Agarwal M, Spartalis C, Manni P, Stuebiger N, et al. COVID-19 vaccination and uveitis: epidemiology, clinical features and visual prognosis. Ocul Immunol Inflamm 2022;30(5):1265-73. doi: 10.1080/09273948.2022.2058964.

Anquetil C, Salem JE, Lebrun-Vignes B, Touhami S, Desbois AC, Maalouf G, et al. Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO’s pharmacovigilance database. J Autoimmun 2020;111:102454. doi: 10.1016/j.jaut.2020.102454.

Iqbal KM, Hay MW, Emami-Naeini P. Medication-induced uveitis: an update. J Ophthalmic Vis Res 2021;16(1):84-92.

Abdalla Elsayed MEA, Kozak I. Pharmacologically induced uveitis. Surv Ophthalmol 2021;66(5):781-801.

Ambler WG, Nanda K, Onel KB, Shenoi S. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives. Ann Med 2022;54(1):1839-50.

Thatayatikom A, Modica R, De Leucio A. Juvenile Idiopathic Arthritis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

Stajszczyk M., Władysiuk M., Rutkowski J. Leczenie chorób zapalnych stawów w Polsce. Wpływ zniesienia ograniczeń czasu leczenia oraz optymalizacji dawkowania w programach lekowych na budżet płatnika publicznego. Kraków: CEESTAHC/Polskie Towarzystwo Reumatologiczne; 2020.

Siiskonen M, Hirn I, Pesälä R, Hautala T, Ohtonen P, Hautala N. Prevalence, incidence and epidemiology of childhood uveitis. Acta Ophthalmol 2021;99(2):e160-3.

Sun N, Wang C, Linghu W, Li X, Zhang X. Demographic and clinical features of pediatric uveitis and scleritis at a tertiary referral center in China. BMC Ophthalmol 2022;22(1):174.

Alzyoud R, Alsuwaiti M, Maittah H, Aladaileh B, Nobani M, Farhan A, et al. Pediatric noninfectious uveitis in a tertiary referral center in Jordan: clinical spectrum and immunomodulatory treatment. Cureus 2022;14(6):e25841.

Marelli L, Romano M, Pontikaki I, Gattinara MV, Nucci P, Cimaz R, et al. Long term experience in patients with JIA-associated uveitis in a large referral center. Front Pediatr 2021;9:682327.

Carlsson E, Beresford MW, Ramanan AV, Dick AD, Hedrich CM. Juvenile idiopathic arthritis associated uveitis. Children (Basel) 2021;8(8):646.

Walscheid K, Glandorf K, Rothaus K, Niewerth M, Klotsche J, Minden K, et al. Enthesitis-related arthritis: prevalence and complications of associated uveitis in children and adolescents from a population-based nationwide study in Germany. J Rheumatol 2021;48(2):262-9.

Del Giudice E, Simio C, Scala A, Di Coste A, La Torre G, Spadea L, et al. Juvenile idiopathic arthritis-associated uveitis in the era of biological therapy: how the disease changed in more than 20 years of observation in a tertiary referral center in Rome (Italy). Int Ophthalmol 2022;42(3):775-84. doi: 10.1007/s10792-021-02043-1.

Angeles-Han ST, McCracken C, Yeh S, Jang SR, Jenkins K, Cope S, et al. HLA associations in a cohort of children with juvenile idiopathic arthritis with and without uveitis. Invest Ophthalmol Vis Sci 2015;56(10):6043-8. doi: 10.1167/iovs.15-17168.

Wennink RAW, de Boer JH, Hiddingh S, Haasnoot AJW, Kalinina Ayuso V, de Hoop T, et al. Next-generation HLA sequence analysis uncovers shared risk alleles between clinically distinct forms of childhood uveitis. Invest Ophthalmol Vis Sci 2021;62(9):19. doi: 10.1167/iovs.62.9.19.

Deng J, Tan H, Hu J, Su G, Cao Q, Huang X, et al. Genetic aspects of idiopathic paediatric uveitis and juvenile idiopathic arthritis associated uveitis in Chinese Han. Br J Ophthalmol 2020;104(3):443-7. doi: 10.1136/bjophthalmol-2018-313200.

Nathan N, Sileo C, Calender A, Pacheco Y, Rosental PA, Cavalin C, et al. Paediatric sarcoidosis. Paediatr Respir Rev 2019;29:53-9. doi: 10.1016/j.prrv.2018.05.003.

Hassan WA, Medhat BM, Youssef MM, Farag Y, Mostafa N, Alnaggar AR, et al. Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study. Clin Rheumatol 2021;40(4):1599-610.

Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 2019;103(10):1418-22. doi: 10.1136/bjophthalmol-2018-313356.

Gundlach E, Temmesfeld-Wollbrück B, Pleyer U. Ocular sarcoidosis: Diagnosis and therapy. Ophthalmologe 2017;114(9):865-76.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for sarcoidosis-associated uveitis. Am J Ophthalmol 2021;228:220-30. doi: 10.1016/j.ajo.2021.03.047.

Mehta PJ, Alexander JL, Sen HN. Pediatric uveitis: new and future treatments. Curr Opin Ophthalmol 2013;24(5):453-62. doi: 10.1097/ICU.0b013e3283641ed.

Kaufman KP, Becker ML. Distinguishing Blau syndrome from systemic Sarcoidosis. Curr Allergy Asthma Rep 2021;21(2):10. doi: 10.1007/s11882-021-00991-3.

Paroli MP, Cappiello D, Staccini D, Caccavale R, Paroli M. Tubulointerstitial nephritis and uveitis syndrome (TINU): a case series in a tertiary care uveitis setting. J Clin Med 2022;11(17):4995.

Pakzad-Vaezi K, Pepple KL. Tubulointerstitial nephritis and uveitis. Curr Opin Ophthalmol 2017;28(6):629-35.

Koreishi AF, Zhou M, Goldstein DA. Tubulointerstitial nephritis and uveitis syndrome: characterization of clinical features. Ocul Immunol Inflamm 2021;29(7-8):1312-7.

Wente-Schulz S, Aksenova M, Awan A, Ambarsari CG, Becherucci F, Emma F, et al. Aetiology, course and treatment of acute tubulointerstitial nephritis in paediatric patients: a cross-sectional web-based survey. BMJ Open 2021;11(5):e047059.

Turowska-Heydel D, Żuber Z. Cewkowo-śródmiąższowe zapalenie nerek i błony naczyniowej oczu. Forum Reumatol 2021;7(3):138-42. doi: 10.5603/FR.2021.0018.

Koné-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, et al. Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 2016;75(6):958-64.

Butbul Aviel Y, Batu ED, Sözeri B, Aktay Ayaz N, Baba L, Amarilyo G, et al. Characteristics of pediatric Behçet’s disease in Turkey and Israel: a cross--sectional cohort comparison. Semin Arthritis Rheum 2020;50(3):515-20.

Shivpuri A, Turtsevich I, Solebo AL, Compeyrot-Lacassagne S. Pediatric uveitis: role of the pediatrician. Front Pediatr 2022;10:874711.

Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology 2021;161(4):1118-32.

Ottaviano G, Salvatore S, Salvatoni A, Martelossi S, Ventura A, Naviglio S. Ocular manifestations of paediatric inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 2018;12(7):870-9.

Shih YJ, Yang YH, Lin CY, Chang CL, Chiang BL. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease. Pediatr Rheumatol Online J 2019;17(1):58.

Yıldız M, Haşlak F, Adroviç A, Şahin S, Barut K, Kasapçopur Ö. Juvenile spondyloartropathies. Eur J Rheumatol 2022;9(1):42-9.

Felis-Giemza A. Spondyloartropatia a zmiany narządowe-kompleksowe podejście do pacjenta. Forum Reumatol 2017;3(3):160-7.

Smith EMD, Lythgoe H, Hedrich CM. Vasculitis in juvenile-onset systemic lupus erythematosus. Front Pediatr 2019;7:149.

Conigliaro P, Cesareo M, Chimenti MS, Triggianese P, Canofari C, Barbato C, et al. Take a look at the eyes in Systemic Lupus Erythematosus: a novel point of view. Autoimmun Rev 2019;18(3):247-54.

Chighizola CB, Ferrito M, Marelli L, Pontikaki I, Nucci P, Miserocchi E, et al. Juvenile idiopathic arthritis, uveitis and multiple sclerosis: description of two patients and literature review. Biomedicines 2022;10(8):2041.

Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for multiple sclerosis-associated intermediate uveitis. Am J Ophthalmol 2021;228:72-9.

Casselman P, Cassiman C, Casteels I, Schauwvlieghe PP. Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol 2021;99(6):592-603.

Brola W, Steinborn B. Pediatric multiple sclerosis – current status of epidemiology, diagnosis and treatment. Neurol Neurochir Pol 2020;54(6):508-17.

Ozdemir HB, Ozdal PC. Clinical characteristics and treatment of pars planitis: an adalimumab experience. Graefes Arch Clin Exp Ophthalmol 2022;260(2):561-9.

Berker N, Sen E, Elgin U, Atilgan CU, Dursun E, Yilmazbas P. Analysis of clinical features and visual outcomes of pars planitis. Int Ophthalmol 2018;38(2):727-36.

Joye A, Suhler E. Vogt–Koyanagi–Harada disease. Curr Opin Ophthalmol 2021;32(6):574-82.

Raizada K, Tripathy K. Eales Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

Hsia NY, Li YL, Lin CJ, Bair H, Lai CT, Lin JM, et al. Ultra-widefield angiography in the diagnosis and management of uveitis. Taiwan J Ophthalmol 2018;8(3):159-63. doi: 10.4103/tjo.tjo_115_17.

Majumder PD, Sitaula RK, Biswas J. Pediatric Eales disease: an Indian Tertiary Eye Center experience. J Pediatr Ophthalmol Strabismus 2018;55(4):270-4. doi: 10.3928/01913913-20180213-01.

Niwald A, Grałek M, Piasecka K, Lipiec E. Biological treatment of chronic non-infectious uveitis in the developmental age. Klin Oczna 2019;121(3):131-5. doi: 10.5114/ko.2019.89728.




DOI: https://doi.org/10.21164/pomjlifesci.1029

Copyright (c) 2024 Monika Modrzejewska, Oliwia Zdanowska, Dawid Świstara

License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/